riluzole has been researched along with Weight Loss in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Weight Loss: Decrease in existing BODY WEIGHT.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aziz, NA | 1 |
van der Burg, JM | 1 |
Landwehrmeyer, GB | 1 |
Brundin, P | 1 |
Stijnen, T | 1 |
Roos, RA | 1 |
Limousin, N | 1 |
Blasco, H | 1 |
Corcia, P | 1 |
Gordon, PH | 1 |
De Toffol, B | 1 |
Andres, C | 1 |
Praline, J | 1 |
1 trial available for riluzole and Weight Loss
Article | Year |
---|---|
Weight loss in Huntington disease increases with higher CAG repeat number.
Topics: Adult; Aged; Animals; Body Mass Index; Body Weight; Disease Models, Animal; Energy Intake; Female; H | 2008 |
1 other study available for riluzole and Weight Loss
Article | Year |
---|---|
Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS.
Topics: Aged; Amyotrophic Lateral Sclerosis; Body Mass Index; Female; Humans; Linear Models; Male; Malnutrit | 2010 |